Quick Answer
Oncology Institute, Inc. reported Operating Income of -$36.08 million for fiscal year 2025.
Oncology Institute, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$36.08M | +40.0% |
| 2024 | -$60.12M | +21.9% |
| 2023 | -$77.02M | +6.0% |
| 2022 | -$81.95M | -78.7% |
| 2021 | -$45.86M | -459.4% |
| 2020 | -$8.20M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.05M | +41.9% | +28.2% |
| June 30, 2025 | -$11.21M | +31.5% | -13.1% |
| March 31, 2025 | -$9.91M | +44.9% | +28.5% |
| September 30, 2024 | -$13.85M | +0.5% | +15.3% |
| June 30, 2024 | -$16.36M | -9.5% | +8.9% |
| March 31, 2024 | -$17.97M | +45.3% | -29.1% |
| September 30, 2023 | -$13.93M | +30.7% | +6.8% |
| June 30, 2023 | -$14.94M | +18.4% | +54.6% |
- Oncology Institute, Inc. showed an increase of +40.0% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Oncology Institute, Inc.’s operating income has declined by 340.2% (from -$8.20 million to -$36.08 million).
- The most recent figure is from Oncology Institute, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: